Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-02

Clinical Trial Update: Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone [Phase 3]

View source ↗

Summary

Phase 3 trial assessing endothelial function in patients with peripheral arterial obstructive disease treated with sulodexide plus conventional treatment versus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulodexide (sulodexide)

Snippet

Sponsor: Alfa Wassermann Tunisia | Conditions: Peripheral Arterial Obstructive Disease | Phase 3 | Status: UNKNOWN